A diagnostic framework that categorizes ADHD patients into clinical subgroups based on specific dopaminergic signaling markers rather than a one-size-fits-all diagnosis.
The SWOT analysis reveals a high-potential shift from behavioral to biological diagnostics, leveraging a critical gap in current ADHD treatment efficacy. While the scientific foundation is strong, the primary hurdles are the transition from theoretical biomarkers to a scalable clinical tool and the resistance of established behavioral diagnostic norms.
Strengths3
Weaknesses3
Opportunities3
Threats3
This provides a necessary first-pass evaluation of the scientific strengths of the dopaminergic approach against the weaknesses of current diagnostic standards. · Generated 2026-10-02 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated